Oral Vaccine Delivery for Intestinal Immunity-Biological Basis, Barriers, Delivery System, and M Cell Targeting. (Q64974251)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

title

Oral Vaccine Delivery for Intestinal Immunity-Biological Basis, Barriers, Delivery System, and M Cell Targeting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Sung Hun Kang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Seok Jin Hong

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

Yong-Kyu Lee

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

publication date

27 August 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

2 May 2020

start time

27 August 2018

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Simultaneous Administration of Live, Enteric-Coated Adenovirus Types 4,7, and 21 Vaccines: Safety and Immunogenicity

1 reference

12 December 2020

Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.

1 reference

12 December 2020

Salmonella-induced M-cell formation in germ-free mouse Peyer's patch tissue

1 reference

12 December 2020

Overview of the mucosal immune system

1 reference

12 December 2020

Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition.

1 reference

12 December 2020

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

1 reference

12 December 2020

Enhancement of cytokine production by macrophages stimulated with (1-->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa

1 reference

12 December 2020

Peripheral deletion of antigen-reactive T cells in oral tolerance.

1 reference

12 December 2020

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

1 reference

12 December 2020

Differential expression of lectin-binding sites defines mouse intestinal M-cells

1 reference

12 December 2020

Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines

1 reference

12 December 2020

Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies

1 reference

12 December 2020

CD4+ T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens.

1 reference

12 December 2020

Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women

1 reference

12 December 2020

Oral Administration of the Immunodominant B-chain of Insulin Reduces Diabetes in a Co-transfer Model of Diabetes in the NOD Mouse and is Associated with a Switch from Th1 to Th2 Cytokines

1 reference

12 December 2020

A Phage Display Technique for a Fast, Sensitive, and Systematic Investigation of Protein–Protein Interactions

1 reference

12 December 2020

Conversion by Peyer's Patch Lymphocytes of Human Enterocytes into M Cells that Transport Bacteria

1 reference

12 December 2020

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 reference

12 December 2020

Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo

1 reference

12 December 2020

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

1 reference

12 December 2020

Human intestinal M cells display the sialyl Lewis A antigen.

1 reference

12 December 2020

Up-regulation of microsphere transport across the follicle-associated epithelium of Peyer's patch by exposure to Streptococcus pneumoniae R36a

1 reference

12 December 2020

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

12 December 2020

Molecular studies of the intestinal mucosal barrier physiopathology using cocultures of epithelial and immune cells: a technical update

1 reference

12 December 2020

Development of oral vaccines for human use.

1 reference

12 December 2020

1 reference

12 December 2020

Exploiting M cells for drug and vaccine delivery

1 reference

12 December 2020

Targeting polymerised liposome vaccine carriers to intestinal M cells

1 reference

12 December 2020

Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence

1 reference

12 December 2020

Anatomical basis of tolerance and immunity to intestinal antigens

1 reference

12 December 2020

Cell culture modeling of specialized tissue: identification of genes expressed specifically by follicle-associated epithelium of Peyer's patch by expression profiling of Caco-2/Raji co-cultures.

1 reference

12 December 2020

Antigen transport into Peyer's patches: increased uptake by constant numbers of M cells

1 reference

12 December 2020

Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland

1 reference

12 December 2020

Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques

1 reference

12 December 2020

Use of fluorescence imaging to investigate the structure and function of intestinal M cells.

1 reference

12 December 2020

Mucosal immunity and vaccines

1 reference

12 December 2020

Immunologic uniqueness of the genital tract: challenge for vaccine development

1 reference

12 December 2020

Targeting antigens to murine and human M-cells with Aleuria aurantia lectin-functionalized microparticles.

1 reference

12 December 2020

Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.

1 reference

12 December 2020

Delivery systems and adjuvants for oral vaccines.

1 reference

12 December 2020

Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses

1 reference

12 December 2020

A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses

1 reference

12 December 2020

Nanotechnology in vaccine delivery

1 reference

12 December 2020

Overview of (1-->3)-beta-D-glucan immunobiology

1 reference

12 December 2020

M cell-targeted delivery of vaccines and therapeutics

1 reference

12 December 2020

Nanotechnology solutions for mucosal immunization

1 reference

12 December 2020

A self-assembling peptide acting as an immune adjuvant

1 reference

12 December 2020

In vitro identification of targeting ligands of human M cells by phage display.

1 reference

12 December 2020

Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique.

1 reference

12 December 2020

Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules

1 reference

12 December 2020

Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells

1 reference

12 December 2020

Roadblocks in the gut: barriers to enteric infection

1 reference

12 December 2020

Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice

1 reference

12 December 2020

Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults

1 reference

12 December 2020

Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery.

1 reference

12 December 2020

M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses

1 reference

12 December 2020

Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route

1 reference

12 December 2020

Formulation design considerations for oral vaccines.

1 reference

12 December 2020

Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes.

1 reference

12 December 2020

Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination

1 reference

12 December 2020

A self-adjuvanting supramolecular vaccine carrying a folded protein antigen

1 reference

12 December 2020

A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac (®) ) in India

1 reference

12 December 2020

Methylated N-(4-N,N-dimethylaminocinnamyl) chitosan-coated electrospray OVA-loaded microparticles for oral vaccination

1 reference

12 December 2020

Mucosal vaccine adjuvants update

1 reference

12 December 2020

Prospects for oral replicating adenovirus-vectored vaccines

1 reference

12 December 2020

Cationic polypeptide micelle-based antigen delivery system: a simple and robust adjuvant to improve vaccine efficacy

1 reference

12 December 2020

Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration.

1 reference

12 December 2020

β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination.

1 reference

12 December 2020

Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells

1 reference

12 December 2020

Review of 10 years of clinical experience with Chinese domestic trivalent influenza vaccine Anflu®

1 reference

12 December 2020

Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan.

1 reference

12 December 2020

Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system

1 reference

12 December 2020

Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines

1 reference

12 December 2020

Nasal-nanotechnology: revolution for efficient therapeutics delivery

1 reference

12 December 2020

A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses

1 reference

12 December 2020

Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation

1 reference

12 December 2020

M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine

1 reference

12 December 2020

M-cell targeted polymeric lipid nanoparticles containing a Toll-like receptor agonist to boost oral immunity

1 reference

12 December 2020

Oral delivery of probiotic expressing M cell homing peptide conjugated BmpB vaccine encapsulated into alginate/chitosan/alginate microcapsules

1 reference

12 December 2020

Starch granules as a vehicle for the oral administration of immobilized antigens

1 reference

12 December 2020

Oral delivery of nanoparticle-based vaccines.

1 reference

12 December 2020

Enhanced mucosal immune responses against tetanus toxoid using novel delivery system comprised of chitosan-functionalized gold nanoparticles and botanical adjuvant: characterization, immunogenicity, and stability assessment

1 reference

12 December 2020

New approaches in oral rotavirus vaccines

1 reference

12 December 2020

Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells.

1 reference

12 December 2020

Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

1 reference

12 December 2020

Heterologous expression of carcinoembryonic antigen in Lactococcus lactis via LcsB-mediated surface displaying system for oral vaccine development

1 reference

12 December 2020

Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer

1 reference

12 December 2020

Development and characterization of alginate coated low molecular weight chitosan nanoparticles as new carriers for oral vaccine delivery in mice.

1 reference

12 December 2020

Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization

1 reference

12 December 2020

Delivery strategies to enhance oral vaccination against enteric infections.

1 reference

12 December 2020

Polio vaccination: past, present and future.

1 reference

12 December 2020

Nasal and pulmonary vaccine delivery using particulate carriers

1 reference

12 December 2020

Attuning hydroxypropyl methylcellulose phthalate to oral delivery vehicle for effective and selective delivery of protein vaccine in ileum.

1 reference

12 December 2020

Synthetic Nanoparticles for Vaccines and Immunotherapy

1 reference

12 December 2020

Peru-15 (Choleragarde(®)), a live attenuated oral cholera vaccine, is safe and immunogenic in human immunodeficiency virus (HIV)-seropositive adults in Thailand

1 reference

12 December 2020

Combinatorial Approach of Antigen Delivery Using M Cell-Homing Peptide and Mucoadhesive Vehicle to Enhance the Efficacy of Oral Vaccine.

1 reference

12 December 2020

β-glucan microparticles targeted to epithelial APN as oral antigen delivery system.

1 reference

12 December 2020

Controlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccines

1 reference

12 December 2020

Systemic administration of RANKL overcomes the bottleneck of oral vaccine delivery through microfold cells in ileum.

1 reference

12 December 2020

Mucosal vaccine delivery: Current state and a pediatric perspective

1 reference

12 December 2020

Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.

1 reference

12 December 2020

New horizons in osteoporosis therapies

1 reference

12 December 2020

Relationship Between Gastrointestinal Events and Compliance With Osteoporosis Therapy: An Administrative Claims Analysis of the US Managed Care Population

1 reference

12 December 2020

Novel nanocarrier for oral Hepatitis B vaccine

1 reference

12 December 2020

Nano-polyplex based on oleoyl-carboxymethy-chitosan (OCMCS) and hyaluronic acid for oral gene vaccine delivery.

1 reference

12 December 2020

Chitosan based nanoparticles as protein carriers for efficient oral antigen delivery

1 reference

12 December 2020

Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era.

1 reference

12 December 2020

Regulatory aspects in the pharmaceutical development of nanoparticle drug delivery systems designed to cross the intestinal epithelium and M-cells

1 reference

12 December 2020

Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection.

1 reference

12 December 2020

Systemic and mucosal immune responses following oral adenoviral delivery of influenza vaccine to the human intestine by radio controlled capsule

1 reference

12 December 2020

Chemical Synthesis, Versatile Structures and Functions of Tailorable Adjuvants for Optimizing Oral Vaccination

1 reference

12 December 2020

Current prospects and future challenges for nasal vaccine delivery.

1 reference

12 December 2020

Oral Gavage Delivery of PR8 Antigen with β-Glucan-Conjugated GRGDS Carrier to Enhance M-Cell Targeting Ability and Induce Immunity

1 reference

12 December 2020

Current state and challenges in developing oral vaccines

1 reference

12 December 2020

Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings

1 reference

12 December 2020

Oral nucleic acid therapy using multicompartmental delivery systems

1 reference

12 December 2020

ROTAVAC® does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial

1 reference

12 December 2020

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

1 reference

12 December 2020

Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery

1 reference

12 December 2020

pH-Responsive Microencapsulation Systems for the Oral Delivery of Polyanhydride Nanoparticles.

1 reference

12 December 2020

Treatment and prevention of HIV infection with long-acting antiretrovirals.

1 reference

12 December 2020

Chitosan nanoparticle antigen uptake in epithelial monolayers can predict mucosal but not systemic in vivo immune response by oral delivery.

1 reference

12 December 2020

Identifiers

DOI

10.3390/POLYM10090948

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json

2 May 2020

PubMed publication ID

30960873

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30960873%20AND%20SRC:MED&resulttype=core&format=json